Purchase Order HHSN272201700436P

<p>This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Bio-Blood Components, Inc. for the provision of 52 units of O+ human red blood cells in CPD at a unit price of $260.00, resulting in a total ceiling value of $14,300.00. The contract has no set-aside designation and a final completion date of May 17, 2017. No further details about a larger contract vehicle or subcontractors are provided.</p>

This is a firm-fixed-price purchase order awarded by the National Institutes of Health (NIH) to Grifols Bio Supplies Inc., a for-profit organization, for the supply of 28 units of O+ human red blood cells (RBC) in CPD. The contract has a ceiling value of $6,860.00 and a period of performance from April 22, 2013 to October 29, 2013, with one unit to be delivered each week. No set-aside was used for this award. This appears to be a standalone contract, and not part of a larger vehicle. The purpose...

This firm-fixed-price purchase order contract was awarded by the National Institutes of Health (NIH) to Grifols Bio Supplies Inc. for the provision of O+ Human Red Blood Cells (RBC) in CPD units. The contract has a ceiling value of $6,760.00 and a period of performance through December 17, 2014. The contract does not have a set-aside designation. Grifols Bio Supplies Inc. is a for-profit organization registered to receive federal contracts, and this award supports medical research and healthcare...

The federal contract award is for the procurement of 52 units of O+ human red blood cells (RBC) in CPD (citrate-phosphate-dextrose) by the National Institute of Allergy and Infectious Diseases, a civilian agency within the Department of Health and Human Services. The contract, valued at $14,250.00, was awarded to Grifols Bio Supplies Inc. as a firm-fixed-price purchase order with no set-aside designation. The contract involves the weekly delivery of one unit of RBCs over a period of 52 weeks,...

This is a $24,720.00 firm-fixed-price purchase order awarded by the National Institutes of Health (NIH) to Grifols Bio Supplies Inc. for the supply of various types of human red blood cells, including leuko-reduced ACD packed red blood cells, O+ human packed red blood cells, and O+ human red blood cells in CPD. The contract is for the Interstate Blood Bank, which provides blood products and related services to support medical research and healthcare operations within the federal government....

This is a $23,760.00 firm-fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services, to Grifols Bio Supplies Inc. for the delivery of 100 units of O+ blood. The contract has an ultimate completion date of January 15, 2015 and does not utilize a set-aside designation. The award is part of NIAID's efforts to procure blood products to support medical research and healthcare operations within...

The federal contract award HHSN272201500183P is for the supply of 26 units of O+ human red blood cells at $255.00 per unit, for a total ceiling value of $7,020.00. The contract was awarded on December 15, 2014 to Grifols Bio Supplies Inc., a for-profit organization, by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services. The contract is a firm-fixed-price purchase order with no set-aside designation. The contract is for...

This is a firm-fixed-price purchase order contract awarded by the National Institutes of Health (NIH) to Grifols Bio Supplies Inc. for the provision of 34 units of O+ human packed red blood cells at a unit price of $255.00, resulting in a total ceiling value of $9,180.00. The contract has no set-aside designation and the work is to be completed by July 6, 2015. Grifols Bio Supplies Inc. is a for-profit organization focused on providing blood products and related services to federal agencies,...

This contract awarded by the Defense Health Agency (DHA) to the Republic of Korea National Red Cross, operating as the Gyeonggi Blood Center Red Cross, is for the delivery of apheresis platelets (A-PLT) in 250 mL units. The contract is a Blanket Purchase Agreement (BPA) call with a firm-fixed-price pricing type, has no set-aside designation, and has an ultimate completion date of December 31, 2024. The ceiling value of this contract award is $8,954.05. The Gyeonggi Blood Center Red Cross, a...

This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services, to Grifols Bio Supplies Inc., a for-profit medical supplies company based in Los Angeles, California. The contract is for the delivery of 8 units of O+ human red blood cells on a biweekly basis, with a ceiling value of $1,920.00 and a completion date of February 1, 2014. The contract does not have a...